Your career starts on Magnet.me
Create a profile and receive smart job recommendations based on your liked jobs.
Pleased to meet you, we are Galapagos, a biotechnology company with operations in Europe and the U.S. dedicated to developing transformational medicines for more years of life and quality of life.
We are in the business of changing lives. Focusing on high unmet medical needs, we synergize compelling science, technology, and collaborative approaches to create a deep pipeline of best-in-class small molecules, CAR-T therapies and biologics in oncology and immunology. With capabilities from lab to patient, including a decentralized CAR-T manufacturing network, we are committed to challenging the status quo and delivering results for our patients, employees and shareholders.
For our Cell Therapy organization in Leiden, we are looking for a Senior Technical Writer contractor to join us for a 6-month assignment.
Project Scope
We are seeking a Senior Technical Writer to work with the Global MSAT and the Viral Vector team in the Leiden Bio Science Park, The Netherlands. In this role you will play a key role in ensuring high-quality, compliant, and scientifically sound documentation to support process and analytical development, validation, and regulatory readiness in a cell therapy environment.
Your mission
Who are you?
What's in it for you?
At Galapagos, we are committed to building meaningful partnerships with our consultants, offering a collaborative and supportive environment where you are recognized as an integral part of the team. As a consultant, you will engage in a variety of projects, enabling you to expand your expertise across multiple domains. Our aim is to support your professional growth while fostering a dynamic workplace that values and empowers you as an equal partner.
We’re in the business of changing lives. In our quest to discover, develop and deliver life-improving medicines, we go where no one has ever gone before.
Galapagos is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action. Galapagos’ pipeline comprises Phase 3 through to discovery programs in cystic fibrosis, inflammation, fibrosis, osteoarthritis and other indications.
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.